genome replicates within a ribonucleoprotein complex, on the ER-derived modified membranous structures termed as "membranous web" (6) (7) (8) . The viral replication complex is assembled in close proximity to cytosolic lipid droplets (LDs) and this arrangement promotes subsequent steps of viral assembly/morphogenesis.
HCV alters host lipid metabolism and causes the redistribution and accumulation of LDs around the perinuclear region (9, 10) . The viral core protein closely associates with LDs and recruits NS5A and these interactions are critical for efficient viral assembly process (11) . Evidence suggests that HCV secretion is linked to cellular very lowdensity lipoprotein (VLDL) secretion (12) . HCV secretion is inhibited by silencing apolipoprotein B-100 (ApoB), ApoE and ApoC1 as well as inhibition of MTP activity (13) (14) (15) . These and other data strongly argue for the utilization of the VLDL secretory pathway by HCV for its maturation/secretion (12, 16) . Although the VLDL secretion pathway is not completely characterized, it is believed to occur through the Golgi network (17, 18) . The exact pathway that results in the association of HCV nucleocapsids (either enveloped or non-enveloped) with the VLDL particles en route to the Golgi compartment remains to be characterized. Similarly the role of lipid droplets in HCV morphogenesis remains to be clearly understood.
OSBP is a sterol sensor and facilitates trafficking of cholesterol or hydroxycholesterol from ER to Golgi (19, 20) . OSBP binds to both VAP-A on the ER and phosphatidylinositol 4-phosphate (PI4P) on the Golgi to form "membrane contact site" (MCS) to facilitate lipid transfer between opposing surfaces (21) . CERT, which shares functional homology with OSBP, regulates the transport of ceramide from ER to the Golgi, where the ceramide is converted to sphingolipids (22) . OSBP modulates CERT activation and translocation to the Golgi, and thereby integrates sterol homeostasis to sphingolipid biosynthesis (21, 23) . We previously showed that OSBP mediates HCV secretion while binding to NS5A
and VAP-A (24) . Inhibition of CERT function effectively suppressed HCV release without affecting RNA replication (25) . These studies indicate that these lipid transport proteins, CERT and OSBP directly contribute to the HCV morphogenesis/secretion. PKD is a serine/threonine kinase and exists in three distinct isoforms (PKD1, PKD2, PKD3). PKD regulates multiple cellular processes including cell survival, adhesion, motility and differentiation (26, 27, 28) . In addition, PKD promotes the fission of cargo vesicles from the TGN and thus regulates the secretion of these vesicles from TGN to the plasma membrane (26, 28, 29) . PKD is recruited to the Golgi through the interaction between diacylglycerol (DAG) and its cysteine-rich C1a domain (27) (28) (29) . The Golgi associated PKD is activated by a novel PKC isoform PKCη by phosphorylation of serine residues in the "activation loop" of PKD (30) These studies identify the key role of the Golgi network in HCV maturation process.
Experimental Procedures
Plamsids-The plasmids pJC1 and p7-RLuc2A were kind gifts of Drs. and shPKD1-2 (36) were described previously.
pcDNA3-Flag-CERT and pcDNA3-Flag-CERT S132A expression vectors were gifts from Dr.
Juan Saus and Dr. Manilola Olayioye, respectively and described previously (31, 37) . pFLAG-CMV-OSBP was described previously (24) . pFLAG-CMV-OSBP S240A was constructed by PCR mediated site-directed mutagenesis using Electroporation was performed using Cytomix buffer (39) as described previously (24) .
HCV infection, focus-forming unit assay and HCV secretion assay-Initial infection was carried out by transfecting Huh7.5.1 cells with in vitro synthesized JC1 RNA. Cultured supernatants were collected at 10 days after transfection, and titrated by focus-forming assay (FFU) described previously (40) . Intracellular infectivity assay was carried out as described previously (14) . Briefly, the collected cells were resuspended in culture medium and lysed by four freeze thaw cycles. The Confocal immunofluorecense microscopy was performed as described previously (24) .
ssHRP-FLAG secretion assay-ssHRP-FLAG secretion assay was carried out as described previously (28) . HCV infected and uninfected Huh 
RESULTS

HCV infection impairs PKD1 protein activity.
PKD regulates the trafficking of secretory vesicle by promoting the fission of these vesicles from trans-Golgi network (28) . In this study, we ( Fig 2B) . In addition, we observed a gradual dose dependent decline in replication of both p7-Rluc2A and its ΔE1E2 counterpart upon treatment with Go6976 ( Fig. 2C and D) . However, with the broad-spectrum PKC inhibitor Go6983, the results on replication of p7-Rluc2A and the ΔE1E2 deletion mutant were rather inconsistent. The intracellular infectivity of Go6976 treated cells was also less than that of untreated control and Go6983 treated cells (Fig. S2A) , whereas the extracellular infectivity increased upon Go6976 treatment ( Fig. S1B ) (28) . Similarly, VLDL secretion was also inhibited by PKD inhibitor Go6976 (Fig.S4 ).
PKD1 inhibition enhances HCV virion release.
In the second approach , we employed shRNA-mediated downregulation of PKD1 using DNA vector-based shRNA expression system to analyze its effect on HCV life cycle. Using two different PKD-specific shRNAs, we could achieve a modest (~50%) reduction of PKD1 protein expression ( Fig. 3A and B) . (Fig. 4C) , in contrast to the HCV replication levels that remained fairly constant in all cases (Fig. 4D) . This modest 2-fold increase is significant considering the presence of endogenous wild type forms of OSBP and CERT.
In addition, we observed that the expression of wild type CERT and OSBP also partially increased HCV secretion, although not as significantly as the expression of mutant forms (Fig. 4C) . Similar results were obtained when wild type or S132A CERT mutant was expressed in the absence of ectopic PKD expression ( Inhibition of PKD has a negative effect on general secretion of protein occurring through the Golgi compartment (Fig. S1 ). PKD inhibition led to a modest decrease in the VLDL secretion ( Fig   S4) . This observation suggests that PKD affects 
